cdk4 glutathione Diet-metabolism-transcription axis modulates the sensitivity to CDK4/6 inhibitors through RB1 in prostate cancer: Cell Reports reduced glutathione and breast cancer
reduced glutathione and breast cancer SLC7A11 protects luminal A breast cancer cells against ferroptosis induced by Cyclin D Cdk4,6 Drives Cell Cycle Progression via the Retinoblastoma Protein's C Terminal Helix: Molecular Cell The application and prospect of CDK4 6 inhibitors in malignant solid tumors Journal of Hematology & Oncology Springer Nature Link Addressing delivery and resistance issues of CDK4 6 inhibitors as cancer therapeutics ScienceDirect Discovery of the GSH responsive Y PROTACs targeting ALK and CDK4 6 as a potential treatment for cancer ScienceDirect
Pay in 4 interest-free payments of $7.06 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




